A recent study suggests that people who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass far faster than those who stop conventional lifestyle regimens.
Research printed in a prominent health publication demonstrates that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying these drugs should be aware of the danger of rapid rebound weight gain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of regain implies a reversion to starting weight within about 18 months.
Analyzing Approaches
The research, which reviewed dozens of studies involving thousands of participants, contrasted the outcomes of these new drugs with other pills.
Researchers emphasize that people who lose weight through lifestyle changes alone usually see a slower weight regain—around 100 grams monthly—once they finish.
Understanding the Rapid Rebound
Nutrition scientists suggest the mode of action of the jabs explains the accelerated rebound.
The injections copy a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this medication leads to hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Disease?
The NHS advise the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Professionals contend that, due to the high risk of weight regain, the treatment should be considered ongoing.
This view is echoed by pharmaceutical companies, who state that the results "emphasize the long-term character of excess weight," akin to managing conditions like high blood pressure.
Patient Experiences
People who have stopped the jabs report a intense return of cravings.
"It was like a trigger flipping and you become ravenous," described one woman.
This challenge is worsened if users have not established sustainable lifestyle or habit modifications during treatment.
Widespread Adoption
Figures show that millions of adults in the UK have used these injections in the past year, with desire being substantial.
- Use is higher among women compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, researchers emphasize that while these medications are powerful agents for weight loss, they are not a standalone fix and lasting health benefits hinges on ongoing lifestyle changes.
